Dr. Morris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1405 Clifton Rd NE
Atlanta, GA 30322Phone+1 404-785-7141Fax+1 404-785-7989
Education & Training
- Children's Hospital-OaklandResidency, Pediatrics, 1993 - 1996
- Eastern Virginia Medical SchoolClass of 1993
- Children's Hospital-OaklandFellowship, Pediatric Emergency Medicine (Pediatrics)
Certifications & Licensure
- CA State Medical License 1994 - 2026
- GA State Medical License 2012 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Emergency Medicine
Clinical Trials
- Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension Start of enrollment: 2009 Mar 01
- Arginine Therapy in Sickle Cell Disease-VOC Clinical Trial Start of enrollment: 2000 Sep 01
- Sickle Cell Disease Treatment With Arginine Therapy (STArT) Trial Start of enrollment: 2021 Jun 21
Publications & Presentations
PubMed
- 462 citationsLactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sick...Gregory J. Kato, Vicki R. McGowan, Roberto F. Machado, Jane A. Little, James G. Taylor Vi
Blood. 2005-11-16 - 726 citationsExtrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity.Susan R. Webb, Claudia R. Morris, Jonathan Sprent
Cell. 1990-12-21 - 535 citationsDysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.Claudia R. Morris, Gregory J. Kato, Mirjana Poljakovic, Xunde Wang, William C. Blackwelder
JAMA. 2005-07-06
Press Mentions
- Emory and Children's Healthcare of Atlanta Now Part of Nationwide Pediatric Emergency Research Network (PECARN)September 17th, 2019
- Sickle Cell Disease: No Longer the Road Less TravelledDecember 4th, 2018
- Arginine Therapy May Hold New Promise for Sickle Cell PainSeptember 17th, 2013
Grant Support
- Glutamine Therapy For Hemolysis-Associated Pulmonary HypertensionFood And Drug Administration2009–2011
- Nitric Oxide As A Marker For Degree Of Vaso-Occlusion In Sickle Cell DiseaseNational Center For Research Resources2005
- Arginine VOC TrialNational Center For Research Resources2005
- The Role Of Arginase Activity And Limited Arginine Bioavailability In AsthmaNational Center For Research Resources2004–2005
- Pneumonia NONational Center For Research Resources2004–2005
- Arginine/SsdNational Center For Research Resources2004–2005
- NO AsthmaNational Center For Research Resources2004
- Arginine Therapy In Sickle Cell DiseaseNational Heart, Lung, And Blood Institute2000–2004
- Nitric Oxide As Marker For Degree Of VASO Occlusion In SCDNational Center For Research Resources2000–2002
- Arginine Therapy In Sickle Cell Disease: Pilot StudyNational Center For Research Resources2000–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: